| Trial ID: | L4772 |
| Source ID: | NCT05306990
|
| Associated Drug: |
Atorvastatin 40 Mg Oral Tablet
|
| Title: |
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hydroxymethylglutaryl-CoA Reductase Inhibitors|Diabetes Mellitus
|
| Interventions: |
DRUG: Atorvastatin 40 Mg Oral Tablet|DRUG: Rosuvastatin 20 Mg Oral Tablet
|
| Outcome Measures: |
Primary: Mean Change from baseline in Low Density Lipoprotein Cholesterol (LDL-C), A measure of participants with response, Post intervention at week 12 |
|
| Sponsor/Collaborators: |
Sponsor: Helwan University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
108
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-04-20
|
| Completion Date: |
2021-01-31
|
| Results First Posted: |
|
| Last Update Posted: |
2022-04-01
|
| Locations: |
Heart Institute, Cairo, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05306990
|
